First quarter 2024 results
First quarter 2024 results were reviewed by management during a conference call with the financial community on April 25th. The presentation was followed by a Q&A session.
14:30 - 16:00 CET (8:30am – 10am EST)
Upcoming events
15May
BofA Securities Health Care Conference 2024
Speakers: Manuela Buxo - Global Head of Dupixent Franchise & Elizabeth Laws - Global Program Head, Dupixent
12:00
Broker Conference
21May
Barclays European Select Conference
Speaker: Frank Nestle - Global Head of Research, Chief Scientific Officer
12:00
Broker Conference
21May
Berenberg European Conference 2024, Manhattan
Speaker: Frank Nestle - Global Head of Research, Chief Scientific Officer
12:00
Broker Conference
Press releases
Environment, Social, Governance
As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.
Contact Our Investor Relations Team
To join the Sanofi front desk,
Please contact the Global Headquarters in France :
+33 (0)1 53 77 40 00
To contact the Investor Relations team:
46 avenue de la Grande Armée
75017 Paris FRANCE
investor.relations (at) sanofi.com